Annual Revenue
$39.55 M
-$2.46 M-5.85%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual revenue is $39.55 million, with the most recent change of -$2.46 million (-5.85%) on December 31, 2023.
- During the last 3 years, CPIX annual revenue has risen by +$2.11 million (+5.64%).
- CPIX annual revenue is now -22.66% below its all-time high of $51.14 million, reached on December 31, 2011.
Performance
CPIX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$9.09 M
-$763.00 K-7.75%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly revenue is $9.09 million, with the most recent change of -$763.00 thousand (-7.75%) on September 30, 2024.
- Over the past year, CPIX quarterly revenue has dropped by -$267.30 thousand (-2.86%).
- CPIX quarterly revenue is now -36.86% below its all-time high of $14.39 million, reached on June 30, 2011.
Performance
CPIX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$36.79 M
-$1.00 M-2.65%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM revenue is $36.79 million, with the most recent change of -$1.00 million (-2.65%) on September 30, 2024.
- Over the past year, CPIX TTM revenue has dropped by -$2.77 million (-7.00%).
- CPIX TTM revenue is now -28.07% below its all-time high of $51.14 million, reached on December 31, 2011.
Performance
CPIX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CPIX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.8% | -2.9% | -7.0% |
| 3 y3 years | +5.6% | +12.6% | -3.0% |
| 5 y5 years | +34.8% | -2.4% | +7.0% |
CPIX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +9.9% | -20.4% | +9.2% | -12.4% | +2.2% |
| 5 y | 5-year | -5.8% | +15.0% | -20.4% | +12.6% | -12.4% | +8.2% |
| alltime | all time | -22.7% | +270.0% | -36.9% | +554.7% | -28.1% | +2550.6% |
Cumberland Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.09 M(-7.7%) | $36.79 M(-2.6%) |
| Jun 2024 | - | $9.85 M(+15.9%) | $37.79 M(-2.7%) |
| Mar 2024 | - | $8.50 M(-9.1%) | $38.83 M(-1.8%) |
| Dec 2023 | $39.55 M(-5.9%) | $9.35 M(-7.3%) | $39.55 M(+0.6%) |
| Sep 2023 | - | $10.09 M(-7.4%) | $39.32 M(-3.3%) |
| Jun 2023 | - | $10.89 M(+18.0%) | $40.65 M(+1.5%) |
| Mar 2023 | - | $9.22 M(+1.1%) | $40.06 M(-4.6%) |
| Dec 2022 | $42.01 M(+16.7%) | $9.12 M(-20.1%) | $42.01 M(+2.0%) |
| Sep 2022 | - | $11.41 M(+10.8%) | $41.21 M(+8.8%) |
| Jun 2022 | - | $10.30 M(-7.8%) | $37.87 M(+3.4%) |
| Mar 2022 | - | $11.18 M(+34.3%) | $36.62 M(+1.8%) |
| Dec 2021 | $35.98 M(-3.9%) | $8.32 M(+3.1%) | $35.99 M(-5.1%) |
| Sep 2021 | - | $8.07 M(-10.9%) | $37.93 M(-3.0%) |
| Jun 2021 | - | $9.06 M(-14.1%) | $39.10 M(-1.4%) |
| Mar 2021 | - | $10.54 M(+2.7%) | $39.65 M(+5.9%) |
| Dec 2020 | $37.44 M(+8.9%) | $10.26 M(+10.9%) | $37.44 M(+2.6%) |
| Sep 2020 | - | $9.25 M(-3.6%) | $36.49 M(+6.8%) |
| Jun 2020 | - | $9.60 M(+15.2%) | $34.17 M(+0.5%) |
| Mar 2020 | - | $8.33 M(-10.5%) | $33.99 M(-1.2%) |
| Dec 2019 | $34.39 M(+17.2%) | $9.31 M(+34.2%) | $34.39 M(+26.5%) |
| Sep 2019 | - | $6.94 M(-26.4%) | $27.18 M(-5.4%) |
| Jun 2019 | - | $9.42 M(+7.9%) | $28.74 M(-2.5%) |
| Mar 2019 | - | $8.73 M(+315.5%) | $29.49 M(+0.5%) |
| Dec 2018 | $29.34 M(-28.7%) | $2.10 M(-75.3%) | $29.34 M(-24.6%) |
| Sep 2018 | - | $8.49 M(-16.4%) | $38.89 M(-6.5%) |
| Jun 2018 | - | $10.16 M(+18.4%) | $41.60 M(+3.7%) |
| Mar 2018 | - | $8.59 M(-26.3%) | $40.10 M(-2.5%) |
| Dec 2017 | $41.15 M(+24.6%) | $11.65 M(+4.0%) | $41.15 M(+6.7%) |
| Sep 2017 | - | $11.20 M(+29.2%) | $38.58 M(+6.6%) |
| Jun 2017 | - | $8.67 M(-10.1%) | $36.18 M(+3.6%) |
| Mar 2017 | - | $9.64 M(+6.1%) | $34.92 M(+5.8%) |
| Dec 2016 | $33.03 M(-1.5%) | $9.08 M(+3.3%) | $33.03 M(+3.3%) |
| Sep 2016 | - | $8.79 M(+18.6%) | $31.98 M(+2.9%) |
| Jun 2016 | - | $7.41 M(-4.2%) | $31.07 M(-4.6%) |
| Mar 2016 | - | $7.74 M(-3.7%) | $32.57 M(-2.8%) |
| Dec 2015 | $33.52 M | $8.04 M(+1.9%) | $33.52 M(-3.7%) |
| Sep 2015 | - | $7.88 M(-11.5%) | $34.81 M(-5.0%) |
| Jun 2015 | - | $8.91 M(+2.6%) | $36.65 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $8.69 M(-6.9%) | $37.50 M(+1.6%) |
| Dec 2014 | $36.90 M(+15.2%) | $9.33 M(-4.1%) | $36.90 M(+3.3%) |
| Sep 2014 | - | $9.73 M(-0.2%) | $35.73 M(+9.8%) |
| Jun 2014 | - | $9.75 M(+20.5%) | $32.53 M(+8.9%) |
| Mar 2014 | - | $8.09 M(-0.8%) | $29.86 M(-6.8%) |
| Dec 2013 | $32.03 M(-34.4%) | $8.16 M(+25.0%) | $32.03 M(-14.7%) |
| Sep 2013 | - | $6.53 M(-7.8%) | $37.56 M(-13.8%) |
| Jun 2013 | - | $7.08 M(-31.0%) | $43.57 M(-10.8%) |
| Mar 2013 | - | $10.26 M(-25.1%) | $48.85 M(+0.0%) |
| Dec 2012 | $48.85 M(-4.5%) | $13.70 M(+9.3%) | $48.85 M(+1.4%) |
| Sep 2012 | - | $12.53 M(+1.3%) | $48.19 M(-1.1%) |
| Jun 2012 | - | $12.37 M(+20.6%) | $48.71 M(-4.0%) |
| Mar 2012 | - | $10.26 M(-21.3%) | $50.73 M(-0.8%) |
| Dec 2011 | $51.14 M(+11.5%) | $13.03 M(-0.2%) | $51.14 M(+0.4%) |
| Sep 2011 | - | $13.05 M(-9.3%) | $50.93 M(+1.7%) |
| Jun 2011 | - | $14.39 M(+34.9%) | $50.06 M(+7.9%) |
| Mar 2011 | - | $10.67 M(-16.8%) | $46.41 M(+1.2%) |
| Dec 2010 | $45.88 M(+5.4%) | $12.81 M(+5.1%) | $45.88 M(+4.8%) |
| Sep 2010 | - | $12.19 M(+13.5%) | $43.78 M(-3.1%) |
| Jun 2010 | - | $10.74 M(+6.0%) | $45.18 M(+2.1%) |
| Mar 2010 | - | $10.13 M(-5.4%) | $44.26 M(+1.7%) |
| Dec 2009 | $43.54 M(+24.1%) | $10.71 M(-21.2%) | $43.54 M(+2.1%) |
| Sep 2009 | - | $13.60 M(+38.5%) | $42.63 M(+13.3%) |
| Jun 2009 | - | $9.82 M(+4.4%) | $37.64 M(+4.0%) |
| Mar 2009 | - | $9.40 M(-4.1%) | $36.18 M(+3.1%) |
| Dec 2008 | $35.08 M(+25.0%) | $9.81 M(+14.0%) | $35.08 M(+7.3%) |
| Sep 2008 | - | $8.60 M(+2.9%) | $32.70 M(+4.0%) |
| Jun 2008 | - | $8.36 M(+0.6%) | $31.43 M(+3.2%) |
| Mar 2008 | - | $8.30 M(+11.7%) | $30.46 M(+8.5%) |
| Dec 2007 | $28.06 M(+57.5%) | $7.43 M(+1.3%) | $28.06 M(+5.2%) |
| Sep 2007 | - | $7.34 M(-0.6%) | $26.68 M(+6.3%) |
| Jun 2007 | - | $7.38 M(+25.0%) | $25.10 M(+12.4%) |
| Mar 2007 | - | $5.91 M(-2.4%) | $22.33 M(+25.4%) |
| Dec 2006 | $17.82 M(+66.7%) | $6.05 M(+5.1%) | $17.82 M(+51.4%) |
| Sep 2006 | - | $5.76 M(+24.7%) | $11.76 M(+95.9%) |
| Jun 2006 | - | $4.62 M(+232.8%) | $6.01 M(+332.8%) |
| Mar 2006 | - | $1.39 M | $1.39 M |
| Dec 2005 | $10.69 M | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual revenue year-on-year change?
- What is Cumberland Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly revenue year-on-year change?
- What is Cumberland Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM revenue year-on-year change?
What is Cumberland Pharmaceuticals annual revenue?
The current annual revenue of CPIX is $39.55 M
What is the all time high annual revenue for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual revenue is $51.14 M
What is Cumberland Pharmaceuticals annual revenue year-on-year change?
Over the past year, CPIX annual revenue has changed by -$2.46 M (-5.85%)
What is Cumberland Pharmaceuticals quarterly revenue?
The current quarterly revenue of CPIX is $9.09 M
What is the all time high quarterly revenue for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly revenue is $14.39 M
What is Cumberland Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, CPIX quarterly revenue has changed by -$267.30 K (-2.86%)
What is Cumberland Pharmaceuticals TTM revenue?
The current TTM revenue of CPIX is $36.79 M
What is the all time high TTM revenue for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM revenue is $51.14 M
What is Cumberland Pharmaceuticals TTM revenue year-on-year change?
Over the past year, CPIX TTM revenue has changed by -$2.77 M (-7.00%)